Paclitaxel Protein-bound Particles For Injectable Suspension (albumin-bound)

List of products in the National Drug Code with proprietary name paclitaxel protein-bound particles for injectable suspension (albumin-bound). Paclitaxel is used to treat various types of cancer. It is a cancer chemotherapy drug that works by slowing or stopping cancer cell growth.

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Labeler Name Product Type
24979-710Paclitaxel Protein-bound Particles For Injectable Suspension (albumin-bound) PaclitaxelInjection, Powder, Lyophilized, For SuspensionIntravenousUpsher-smith Laboratories, LlcHuman Prescription Drug
68001-651Paclitaxel Protein-bound Particles For Injectable Suspension (albumin-bound) PaclitaxelInjection, Powder, Lyophilized, For SuspensionIntravenousBluepoint LaboratoriesHuman Prescription Drug
71288-183Paclitaxel Protein-bound Particles For Injectable Suspension (albumin-bound) PaclitaxelInjection, Powder, Lyophilized, For SuspensionIntravenousMeitheal Pharmaceuticals Inc.Human Prescription Drug
72603-408Paclitaxel Protein-bound Particles For Injectable Suspension (albumin-bound) PaclitaxelInjection, Powder, Lyophilized, For SuspensionIntravenousNorthstar Rx LlcHuman Prescription Drug
60505-6230Paclitaxel Protein-bound Particles For Injectable Suspension (albumin-bound) Apotex Corp.